DR:EAM study: Exploring eye drops for diabetic retinopathy
The DR:EAM study in investigating novel eye drop OTT-166 for the treatment of diabetic retinopathy in hopes of reducing treatment burden for patients.
ASCRS 2023: The safety of office space cataract surgeries
Lance Kugler, MD, recapped his presentation and findings on the safety of office space cataract surgery with the Ophthalmology Times© team at the ASCRS annual meeting in San Diego.
ASCRS 2023: Analysis in two subgroups of routine cataract surgery
Edward Hu, MD, PhD, discussed his paper on the single surgeon retrospective comparative analysis of 517 eyes of two subgroups of routine cataract surgery at the 2023 ASCRS annual meeting in San Diego.
ASCRS 2023: Progressive keratoconus in older patients with delayed corneal cross-linking treatment
William Trattler, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on progressive keratoconus in older patients with delayed corneal cross-linking treatment at the ASCRS annual meeting in San Diego.
ASCRS 2023: Use of intraoperative OCT during glaucoma surgery
Inder Paul Singh, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on intraoperative OCT during glaucoma at the ASCRS annual meeting in San Diego.
ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes
Alvin Liu, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on deep learning and 3D OCT at the ASCRS annual meeting in San Diego.
ASCRS 2023: Predicting vision outcomes in cataract surgery with machine learning
Mark Packer, MD, sat down with Sheryl Stevenson, Group Editorial Director, Ophthalmology Times®, to discuss his presentation on machine learning and predicting vision outcomes after cataract surgery at the ASCRS annual meeting in San Diego.
Controversies in Modern Eye Care 2023: Catching the signs and symptoms of thyroid eye disease
April 30th 2023Selina McGee, OD, FAAO, Dipl ABO, shares highlights from her featured symposium, "Thyroid eye disease: The masquerading eye disorder," which she co-presented during the 2023 Controversies in Modern Eye Care meeting.
ARVO 2023: Human donor tissue to identify mechanism of retinal pigment epithelium death
Deborah Ferrington, PhD, shares a brief overview of her presentation on identifying the mechanism responsible for the death of the retinal pigment epithelium.
ARVO 2023: Lexitas presents its modified NEI scale
Andrew Pucker, OD, MS, PhD, FAAO, and George Magrath, MD, discuss Lexitas Pharma Services' work on modification of the National Eye Institute's corneal fluorescein staining scale.
ARVO 2023: Managing myopia progression with low concentration atropine
Mark Bullimore, PhD, MCOptom, shares a brief overview of her presentation on myopia management by slowing progression with low concentration atropine.
IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.